BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16232345)

  • 1. Photoselective vaporization of the prostate in the treatment of benign prostatic hyperplasia.
    Fu WJ; Hong BF; Yang Y; Cai W; Gao JP; Wang CY; Wang XX
    Chin Med J (Engl); 2005 Oct; 118(19):1610-4. PubMed ID: 16232345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives.
    Schatzl G; Madersbacher S; Lang T; Marberger M
    J Urol; 1997 Jul; 158(1):105-10; discussion 110-1. PubMed ID: 9186334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urodynamic effects of Prolase 2 laser prostatectomy in benign prostatic hyperplasia.
    Van Erps P; Schapmans S; Cortvriend J; D'Hont C; Denis LJ
    Acta Urol Belg; 1995 Sep; 63(3):39-43. PubMed ID: 7484521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transurethral needle ablation of the prostate: report of initial United States clinical trial.
    Issa MM
    J Urol; 1996 Aug; 156(2 Pt 1):413-9. PubMed ID: 8683692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized study comparing visual laser ablation and transurethral evaporation of prostate in the management of benign prostatic hyperplasia.
    Narayan P; Tewari A; Aboseif S; Evans C
    J Urol; 1995 Dec; 154(6):2083-8. PubMed ID: 7500464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transurethral electrovaporization of the prostate: a novel method for treating men with benign prostatic hyperplasia.
    Kaplan SA; Te AE
    Urology; 1995 Apr; 45(4):566-72. PubMed ID: 7536365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of transurethral resection of the prostate using a modified electro-vaporizing loop and transurethral laser vaporization of the prostate.
    Kaplan SA; Te AE
    J Urol; 1995 Nov; 154(5):1785-90. PubMed ID: 7563347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transurethral incision of the prostate using the holmium:YAG laser: a catheterless procedure.
    Cornford PA; Biyani CS; Powell CS
    J Urol; 1998 Apr; 159(4):1229-31. PubMed ID: 9507841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transurethral vaportrode electrovaporization of the prostate: physical principles, technique, and results.
    Narayan P; Tewari A; Garzotto M; Parramore HW; Schalow E; Starling J; Jones T
    Urology; 1996 Apr; 47(4):505-10. PubMed ID: 8638358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The VLAP system (Visual Laser Ablation of the Prostate): comparative study of the contact versus non-contact techniques in a series of 100 cases].
    Breteau D; Koutani A; Albert P; Morin N; Salvo A
    Prog Urol; 1997 Apr; 7(2):235-9. PubMed ID: 9264765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-Phyto Study group.
    Klippel KF; Hiltl DM; Schipp B
    Br J Urol; 1997 Sep; 80(3):427-32. PubMed ID: 9313662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory parameters following contact laser ablation of the prostate for benign prostatic hypertrophy.
    Gomella LG; Lotfi MA; Reagan GN
    Tech Urol; 1995; 1(3):168-71. PubMed ID: 9118387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting change in quality of life after prostatectomy for benign prostatic hypertrophy: the impact of surgical techniques.
    Mozes B; Cohen YC; Olmer L; Shabtai E
    J Urol; 1996 Jan; 155(1):191-6. PubMed ID: 7490831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel transurethral microwave thermal ablation system to treat benign prostatic hyperplasia: results of a prospective multicenter clinical trial.
    Ramsey EW; Miller PD; Parsons K
    J Urol; 1997 Jul; 158(1):112-8; discussion 118-9. PubMed ID: 9186335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial human clinical experience with diode laser interstitial treatment of benign prostatic hyperplasia.
    Muschter R; de la Rosette JJ; Whitfield H; Pellerin JP; Madersbacher S; Gillatt D
    Urology; 1996 Aug; 48(2):223-8. PubMed ID: 8753733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electrovaporization of the prostate].
    Cecchi M; Sepich CA; Pagni G; Ippolito C; Summonti D; Fiorentini L
    Chir Ital; 1996; 48(5):27-34. PubMed ID: 9206615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized study to compare biodegradable self-reinforced polyglycolic acid spiral stents to suprapubic and indwelling catheters after visual laser ablation of the prostate.
    Pétas A; Talja M; Tammela T; Taari K; Lehtoranta K; Välimaa T; Törmälä P
    J Urol; 1997 Jan; 157(1):173-6. PubMed ID: 8976244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transurethral interstitial laser coagulation for benign prostatic hyperplasia: treatment outcome and quality of life.
    Arai Y; Ishitoya S; Okubo K; Suzuki Y
    Br J Urol; 1996 Jul; 78(1):93-8. PubMed ID: 8795408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transurethral endoscopic electrovaporization in the treatment of patients with benign prostatic hyperplasia].
    Martov AG; Kamalov AA; Razumov SV
    Urol Nefrol (Mosk); 1997; (4):3-5. PubMed ID: 9381618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and complications of intraprostatic prosthesis in the treatment of benign hyperplasia of the prostate].
    Clemente Ramos L; Burgos Revilla FJ; Fernández Fernández E; Jiménez Cidre M; Cruz Guerra N; Escudero Barrilero A
    Arch Esp Urol; 1997 Sep; 50(7):773-80. PubMed ID: 9412383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.